ARTICLE
4 December 2013

President Signs Drug Quality And Security Act

FR
Fox Rothschild LLP

Contributor

Who We Are

With bold growth, Fox Rothschild brings together 1,000 attorneys coast to coast. We offer the reach and resources of a national law firm combined with the personal touch and connections of a boutique firm.

Our Mission

Solving problems is our top priority. We invest the time to get to know you and understand your needs. We work hard to win every client’s loyalty. We do that by providing creative solutions and excellent client service.

On November 27, 2013, President Obama signed the Drug Quality and Security Act, which amends the Food, Drug, and Cosmetic Act.
United States Food, Drugs, Healthcare, Life Sciences
Fox Rothschild LLP are most popular:
  • within Immigration, Litigation and Mediation & Arbitration topic(s)
  • with Senior Company Executives and HR
  • in United States
  • with readers working within the Automotive, Basic Industries and Insurance industries

On November 27, 2013, President Obama signed the Drug Quality and Security Act, which amends the Food, Drug, and Cosmetic Act.  The bill was originally introduced in the House of Representatives (as H.R. 3204) and significantly alters the regulation of compounded drugs.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More